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Cellular destruction by in vitro sensitized lymphocytes is mediated by cyto-
toxic T lymphocytes (CTLs)I in the cell-mediated lympholysis (CML) assay (1-
7) . Target cells that bear major histocompatibility complex (MHC) antigens in
common with the sensitizing cell are lysed . Studies ofMHC recombinants have
demonstrated that the strongest of these antigens recognized by CTLs are
genetically controlled by the regions of the MHC that control the serologically
defined (SD) antigens, andmay in fact be the SD antigens themselves (8-13) .
We here describe a sensitive human CML method that frequently detects
significant cytotoxicity against "third-party" target cells unrelated to the stimu-
lating cell donor when the lysis of autologous lymphocytes by the same CTLs
does not differ from zero . This "cross-killing" has been detected even when the
stimulating cells and third-party cells have no shared or cross-reacting SD
antigens by serological criteria (14) .
The specificity of this cross-killing has been examined by using a CML-
blocking technique in which unlabeled target cells added to the test culture
competitively inhibit lysis of s'Cr-labeled targets (15-17) . These experiments
demonstrate that cross-killing of third-party target cells by human CTLs re-
quires the recognition of specific antigenic determinants that were present on




Human peripheral blood lymphocytes were obtained from healthy nonimmu-
nized human donors and purified by Ficoll-Hypaque gradient flotation .
Cell-Mediated Lympholysis (CML)
IN VITRO SENSITIZATION .
￿
12 x 108 mitomycin-C-treated "stimulating" cells and 9 x 108 un-
treated "responding" cells are cultured together in upright 50-ml tissue culture flasks (Falcon
Plastics, Div . of BioQuest, Oxnard, Calif.) containing 10-20 ml of "final medium," which consists
ofRPMI-1640containing 25 mMHEPESbuffer (Grand Island Biological Co ., Grand Island, N. Y.)
* This work is supportedbyNIH grants AI-11576, AI-08439, GM-15422, CA-14520, CA-16836 and
NF MOD grantCRBS 246 . This is paperno. 1844 from the Laboratory ofGenetics and paperno . 32
from the Immunobiology Research Center, The University of Wisconsin, Madison, Wisconsin .
' Abbreviations used in this paper: CML, cell-mediated lympholysis ; CTLs, cytotoxicT lympho-
cytes; MHC, major histocompatibility complex ; MLC, mixed lymphocyte cultures ; SD, serologi-
cally defined .
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supplemented with 4 MM L-glutamine (GIBCO) 1.2% Penicillin-Streptomycin (Grand Island
Biological Co .), and 20%heat-inactivated human serum. These flasks are incubated for6days in a
37°C, 95% air, and 5% C02 humid atmosphere, afterwhich all cells are harvestedand resuspended
in finalmedium after washingonce . All cell populations obtained by this method are referred to as
CTLs even when no cytotoxic activity is demonstrated .
TARGETS AND BLOCKERS .
￿
At the same time that sensitization cultures are established, 5-30 x
106 lymphocytes are cultured in upright 50-ml tissue culture flasks containing 10-20 ml final
medium . On day 6, 5-10 x 106 of these cells are labeled with "Cr as described previously (7), and
resuspended at 1 x 105 radiolabeled cells/ml . The remaining unlabeled target cells are resus-
pended at varying concentrations and will be referred to as "blockers."
STANDARD "Cr-RELEASE ASSAY . Cytotoxicity assays are performed in 10 x 75 mm glass test
tubes (Kimble Div., American Hospital Supply Corp ., Evanston, Ill.) by adding 0.1 ml of "Cr-
labeled target cells (1 x 10° cells) to 0.2 ml ofCTLsuspensions ofvarying concentrations . Theseare
centrifuged at 150g for 5 minand then incubated in a 37°C, 5% C0 2humidatmosphere for 4 h. Iced
Medium 199 (1 .7 ml) is then added to stop thereaction and resuspend all cells . Tubes are spun at
600g for 10 min, andthe"Crcontaining supernates aredecanted into glass tubes and counted for
5'Crcontent in agammacounter (Packard Instrument Co ., Inc., Downers Grove, Ill.) . "Cr-release
data (mean counts per minute of triplicates ± SD) are expressed as percent cytotoxicity :
% cytotoxicity =
￿
(exp . - SR)
￿
x 100
(max . - SR)
where (SR) is the"Cr released spontaneously during 4hby 1 x 10 4 labeled target cellsalone ; max.
is the "Cr released by 1 x 10° target cells lysed by detergent ; and exp. is the "Cr released by
targets in the presence of CTLs . In CML studiesof 53 different target cell preparations, the "Cr
released by detergent has averaged 87.2%of the total "Crincorporated into thetarget cells, while
the spontaneous release value has averaged 11.1% ofthe total .
This CML method sensitively detects cytotoxic activity directed at target cells to which
responding lymphocyteshave been sensitized . Cytotoxicity by two CTLs pertarget averaged 29 .5
± 13.5%, and in every combination of unrelated individuals tested, the killing by one CTL per
target hasbeen significantlygreater than zero . In contrast,the"autokilling"observedby specifically
sensitized CTLs tested at ratios of 10 or moreper autologous target cell hasaveraged -0.1 x 1 .2%.
CML-BLOCKING STUDIES.
￿
Specific CML blocking is performedby adding 0.2 ml of "blocker" cell
suspension to each tube before the addition of CTLs . Analysis of"Cr data obtained from these
blocking experiments will be discussed in the Results section .
Proliferative Studies . Mixed lymphocyte cultures (MLC) are performed by the method of
Hartzman et al . (18) in final medium (described above) .
HL-A SD Typing .
￿
Serological detection of HL-ASD specificities was kindly performedby Dr .
RudolfWank usinga modifed two-stage microcytotoxicity assay (19) . Testingwas performed with
at least 120separate alloantisera which detect eleven alleles of theLA locus and 14 alleles of the
Four locus . Due to lack ofantisera, alleles of thethirdSD locus (AJ) have not been identified for
these studies (20) .
Results and Discussion
Magnitude of "Cross-Killing ."
￿
Extensive human CML studies have corre-
lated the magnitude of cytotoxicity on third-party target cells unrelated to the
initial MLC-stimulating cells with the number of shared serologically detected
(SD) antigens (8, 12) . If individualsB and C are picked at random, or share no
SD antigens by serological criteria, previous reports have found no or low levels
of significant cross-killing of C targets by CTLs from an AB,, culture (4, 9, 10) .
Using the present CML method, the cross-killing has often been remarkably
high, even when the specific sensitizing and third-party cells have no shared or
cross-reacting SD antigens (14) .
In the experiment presented in Table I, CTLs mediate significant cytotoxicityCTLs






CTLs from the indicated MLC as well as unstimulated cells from Z, were tested on target cells
from individuals W, X, Y, andZ. No cross-reacting or shared antigens were detected serologically
amongindividuals W, X, and Y. Typing results are as follows: W, (1, 8); X, (2, 12); Y, (10, 7, 27);
andZ, (10, 11, W15, W16) . Percentcytotoxicity by 25 x 10° CTLs on 1 x 10°target cells are shown.
Potency values in parentheses represent the number of specifically sensitized cells from Z that
cause thesame percentcytotoxicity as 25 x 101oftheCTLs beingexamined. Potencyvalues were
interpolated from a log-linear graph of several specific CTL concentrations vs. percent cytotoxic-
ity. Controlvalues foreach target ("Cr cpm): W: SR, 211 ± 20; max., 1,913 ± 22; X: SR, 206 ± 16;
max, 1,089 ± 46; Y: SR, 246 ± 30; max. = 1,597 ± 50; Z: SR, 322 ± 42; max., 1,714 ± 72 .
on third-party targets bearing no serologically detectable cross-reactivities with
the sensitizing cell donor. Each of the cross-killing combinations demonstrate
that "cross-reactivities" not detectable by current serological methods can be
identified by in vitro-sensitized CTLs; the biological significance of these cross-
reactivities remains unclear. For example, the destruction of X targetsby CTLs
from the ZW.(ZW./*X) mixed culture does not prove the existence of antigenic
determinants shared by X and W that are recognized by Z, even though this
relationship is often assumed. Several other specific andnonspecific mechanisms
of CML cross-killing are possible; these have been tested experimentally using
the CML-blocking method .
Antigen-Specific Blocking of CML.
￿
The amount of cytotoxicity observed
using this and most other CML assays is roughly proportional to the log of the
CTL to target (K/T) ratio. This ratio is usually diminished by decreasing the
number of CTLs whilethe number of "Cr-labeledtargets is fixed. If the number
of CTLs and target cells were fixed and the K/T ratio was decreased by the
addition of unlabeled target cells, one would also predict a decrease in the
percent cytotoxicity. This is the rationalebehind the CML-blocking method (15-
17).
In the absenceof CTLs, theblockers alone cause little or no variationfrom the
SR value. This allows all 5'Cr release data to be calculated with the SR
corresponding to 0% killing, even in the presence of blockers. In Table II, any
inhibition of CML caused by the autologous L blockers must be due to steric
effects (i .e, nonspecific physical interference with the interaction between CTLs
and labeled targets). In every combination tested the specific Q blockers in-
hibited the cytotoxicity to a greater degree than the L blockers, thereby demon-
strating antigen-specific blocking.
Two separate approaches toward the quantitation of blocking data are pre-
sented. The percent "specific blocking", given in column A, indicates what
fraction of the cytotoxicity obtained in the presence of autologous L blockers is
W X Y Z
ZWm 62.5±2.8(28) 55.9±3.2(10) 38.5±2.7(2) 1.7±3.9
ZXm 48.5 ± 4.3 (10) 67.6 ± 6.2 (25) 29.3 ± 3.5 (1) 0.3 ± 3.1
ZYm 40.7 ± 3.8 (6) 28.6 ± 2.3 (2) 68.9 ± 3.4 (25) -1.6 ± 3.2
Z- 0.4±1.7 -3.1±2.3 -1.7±2.5 -1342 RECOGNITIVE SPECIFICITY OF HUMAN CYTOTOXIC T LYMPHOCYTES
Blockers x
TABLE II
Quantitation of CML Blocking
s'Crreleased by 1 x 10'Q targets incubated with 50 x 104 CTLs from an LQmculture wasmeasured
in the presence ofvarying numbers ofLor Qblockers. "Crdata is expressed as the mean cpm ±
SD of triplicate cultures. The percent cytotoxicity is based on thefollowing spontaneous release
(SR) andmaximumrelease (max.) values (mean5'Cr cpmoftriplicates ± SD): SR,337 ± 33; max.,
2,361 ± 70.
* Percent specific blocking = 100 x (CML units with autologous blockers - CML units with
allogeneic blockers)/(CML units with autologous blockers), where "autologous blockers" are
from the responding cell donor.
# CTLpotency is determined by interpolatingthecytotoxicity obtained in thepresence ofblockers
to the plot of cytotoxicity vs. log (K/T) obtained with varying numbers of unblocked CTLs (not
shown). The potency of any CML combination is the number of unblocked CTLs which would
cause the same percent cytotoxicity as the blocked combination.
§ Percent specific potency inhibition = 100 x (potency ofCTLs with autologous blockers - potency
of CTLs with allogeneic blockers)/(Potency of CTLs with autologous blockers) .
~~ 100 x 10' L blockers were not tested. This 5'Cr-release value was interpolated logarithmically
from values obtained for 50 x 10' and 200 x 10' Lblockers.
inhibited by the same number of specific Q blockers, thereby reflecting the
extent of antigen-specific blocking. These values may not accurately represent
the magnitude of CML inhibition since percent cytotoxicity is not linearly
proportional to the number of CTLs. For this reason we have also presented
CML-blocking data by a second method, (columns B and C). In this case a "CTL
potency" value is calculated (21) . This value reflects the number of specifically
sensitized, but unblocked CTLs that would yield the same percent cytotoxicity
as the blocked combination. For example, the potency of 50 x 10' CTLs in the
presence of 50 x 104 L or Q blocking cells is 17 x 10' and 2 .6 x 10', respectively.
Comparing these last two values demonstrates that 50 x 104 Q blocker cells
inhibit 85% of the CTLs that were active in the presence of 50 x 104 L blockers .
Blocking Analysis of Cross-Killing Specificity .
￿
Monolayer adsorption stud-
ies of CTLs have proven the existence of distinct antigen-reactive cytotoxic cell


















0 - 1,656 ± 64 65.2 50
5 L 1,568 ± 129 60.8 - 37 -
Q 1,325 ± 77 48.8 20 13 65
50 L 1,383 ± 170 51.7 - 17 -
Q 899 ± 24 27.7 46 2.6 85
100 L 1,36011 50.5 - 16 -
Q 682 ± 28 17.0 66 1.3 92
200 L 1,337 ± 91 49.4 - 14 -
Q 477 ± 25 6.9 86 0.7 95PAUL M . SONDEL AND FRITZ H . BACH 1343
autokilling in this CML system, suggests that all cytotoxicity, including cross-
killing, may be mediated by antigen-specific subpopulations ofCTLs . There are
at least two separate mechanisms by which CTLs reactive to antigens on third-
party target cells could be generated in a CML-sensitization culture .
NONSPECIFIC ALLOREACTIVE ACTIVATION.
￿
Activation ofA responder cells by
B.-stimulating cells has been shown to induce most of theCTL precursors from
individual A that recognize Bm to differentiate into CTLs specifically cytotoxic
forB. In addition, this activation mechanismmay nonspecifically induce differ-
entiation ofa smallfraction of otherCTLprecursorpopulationsthat are reactive
to CML antigens notpresent on B ; some CTLs able to recognizeantigens present
on C targetsbut not on B, may be activated and therefore cause cross-killing on
C targets .
SPECIFIC ANTIGEN-DEPENDENT ACTIVATION .
￿
Activation of A responder cells
by Bm stimulators may induce only the A cells that are B reactive to become
cytotoxic, leaving "dormant" all cytotoxic precursors not able to recognize anti-
gens on B target cells . The observed killing ofC targets by CTLs from an AB .
MLCwould result from recognition of antigenic determinants present on C that
are also present on B.
Although previous CML reportshaveassumed thatCML cross-killing demon-
strates shared antigens, both of the above possibilities must be considered ; the
mechanism of "nonspecific alloreactive activation" may be particularly rele-
vant to those cases of significant CML cross-killing in the absence of shared or
cross-reacting serologically detectible specificities (25, 26) .
These two mechanisms have been tested by blocking studies ofCML cross-
killing ; in all cases the results have supported the second mechanism . One such
experiment using lymphocytes obtained from three randomly selected unrelated
donors is presented in Fig . 1 . The specific cytotoxicity mediated by CTLs from an
AB. culture on B targets is inhibited from 28.1 to 9.5% cytotoxicity by the
addition ofB blockers, while the same CTLs on B targets are inhibited to a
lesser extent by third-party blockers from individual C, 17.5% cytotoxicity . In
contrast, the cross-killing on C targets is inhibited to the same degree by Band
C blockers . This suggests that all the antigens ABm recognizes on the C targets
are present onB blockers and were presenton the initialB;stimulating cells . If
any of the cross-killing on C targets had been due to nonspecific alloreactive
activation there should have been CTLsfrom theABm culture reactive only to C
and thereby subjectto blockingby C but notB . In such an experiment reciprocal
specificity studies are crucial to prove that the observed result is actually due to
antigen recognition rather than differential steric effects ; as seen in Fig . 1, the
equivalent result is obtained in the reciprocal combinations .
Selective Blocking of Cytotoxic Subpopulations . Experiments using the
aboveprotocolprove that cross-killing ofAB,/*C is notmediated by a subpopula-
tion of nonspecifically activated CTLs reactive only to C and not B. However
these same experiments by themselves cannot prove that cross-killing of C
targets results from the recognition of antigens on the C cells that were also
recognized on Bm in the initialAB. sensitization culture . It could still be argued
that the observed inhibition of ABm/*C by B blockers has no relation to the
recognition of shared target antigens . The unlabeled B target cellsmay block1344
￿
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FIG . 1 .
￿
Control ofCMLblocking by humanMAC. CTLs fromABm and AC , sensitization
cultures are tested on B and C target cells in the presence of A, B, or C blocking cells .
Individuals A, B, and Carerandomly selected unrelated donors . Optimal blocking discrimi-
nation in this experiment was observed with 5 x 104 CTLs and 30 x 10 4 blocking cells ;
parallel results were also obtained using 5 x 104CTLs with 5 x 10 4 blockers, and 30 x 104
CTLs with 30 x 104 blockers (not shown) . Control values for each target: B : SR, 198 ± 27 ;
max., 1,328 ± 92 and C: SR, 239 ± 20 ; max ., 1,619 ± 21 .
ABm/*C via some mechanism related to the presence of Bm as the specific
stimulator, and independent of target antigens present on C . This possibility is
ruled out by experiments in which reactivity to multiple antigens can be
selectively blocked ; CTLs simultaneously stimulated by Em and Fm (Table III)
are effectively blocked onlyby E blockers on E targets, and onlybyF blockers on
F targets .
In total, these experiments demonstrate that CTLs are generated in vitro via
the mechanism of "specific antigen-dependent activation," and that all CML
cross-killing may result from recognition of shared antigens . These data also
suggest that stimulation with several antigenic determinants, whether on two
different allogeneic cells or possibly just on one stimulating cell, induces the
differentiation of different cytotoxic populations for each determinant : these
individual populations may specifically kill or be blocked only by cells bearing
that single antigenic determinant .
CML Blocking is Controlled by theMHC .
￿
In the above studies, blocking of
specific killing (i.e ., ABm/*B) by unrelated third-party blocking populations has
never been as effective as that caused by the specific blocker, suggesting the
absence of at least some specific target antigens from the third-party cells .
However a population of third-party cells bearing all the antigens recognized on
the specific target would be expected to block as well as the specific blocker .
Because CML reactivity is directed primarily against antigens controlled by the
MHC, it is likely that cells from any individual sharing the same MHC recog-
nized on the stimulating cells should block equivalently to the specific blockers .
In Fig . 2, individuals J and K are HL-A LD and SD identical siblings, H is aTargets
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TABLE III
Specific Blocking of Cytotoxic Subpopulations
Cytotoxicity with 50 x 104 ￿Specific






Cytotoxicity mediated by 25 x 104CTLs from DEm , DFm , andDEmFm cultures wasassayed on 1 x
104 E and F targets in the presence of 50 x 104 D, E, or F blockers .
* Percent specific blocking, see Table II legend. Control values for each target : E : SR, 229 ± 6 ;
max., 1,724 ± 48 ; F: SR = 294 ± 9 ; max. = 2,447 ± 40 .
haplo-identical sibling differingby a maternal MHC, andM is their mother . In
this experiment, some CTLs are derived from cultures in which responder and
stimulator are haplo-identical so that any kinship member with the same
stimulating MHC should block. This is observed on both H and J targets;
KH,/*H is blocked similarly byH and M, while HJ,~*J is blocked by J, K, and
M. On both of these targets, blockers from unrelated individual U cause no
significant blocking compared to the blockers autologous to the CTLs . These U
cells, however, were the only effective block ofHU,~*U .
Of importance is the significant killing of U targets by CTLs from the HJm
culture . Individual U has no SD antigens that cross-react with the 1-17 haplo-
type recognized by sibling H on cells from J, K, or M . The cross-killing of U
targets by these CTLs is inhibited significantly by blockers from K, M, andU (P
< 0.005) . The amount of blocking by family members K andM is not signifi-
cantly different from the blocking by U (P > 0.05) . This last combination
demonstrates three separate properties ofCML cross-killing . First, cross-killing
can be observed even when "full-house" typing reveals no cross-reacting SD
determinants . Second, as shown in Fig. 1 and Table III, cross-killing results
from the recognition of antigens shared by the stimulating cell and the third-
party target cells . Third, these shared but serologically undetected antigens are
controlled by the MHC .
Several lines of evidence have mapped the genetic control of CML detected
antigens to the SD regions of the MHC, and have suggested that the serologi-
cally-detected and CML-detected antigens are genetically identical (8-13) . If
this is the case, detection of shared antigens by blocking of CML cross-killing
and not by serological testing suggests that CTLs and antisera recognize differ-
ent submolecular structures of the SD-geneproducts, or they recognize the same
CTLs







DE r ., 36.0±2 .8 13.9±1.1 34.7±2.9 61 4
DFm 20 .5 ± 1.5 0.7 ± 0.8 4.2 ± 2.0 97 80
DEmFm 34 .0 ± 5.0 7.3 ± 1 .8 35 .6 ± 2.7 79 <0
None -0.9 ± 0.9 - -1.7 ± 0.8
DEm 23.8±0 .7 10.03.8 7.0±1.7 58 71
DFm 39.3±2 .4 40.0±6.7 16.1±2.2 <0 59
DEmFm 31 .9 ± 2.3 33 .4 ± 1.8 10.8 ± 2.0 <0 66
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FIG . 2 .
￿
CML cross-killing detects shared antigens . Family Bey . members J and K are
MHC-identical siblings, H is haplo-identical to J and K, M is their mother, andU is an
unrelated individual . HL-A SD specificities for each are: H, 2-14 and 11-5 ; J, 2-14 and 1-17 ;
K, 2-14 and 1-17 ;M, 11-5 and 1-17 ;and U, 2, 12, 13, W29. IndividualUshares antigen 2 with
sibs H, J, and K, but specificities 12, 13, andW29 do not cross-react serologically with any of
the antigen specificities in the family . All results shown on J targets were paralleled on
targets from MHC identical sib K. Similarly, CTLs from an HKm culture demonstrated
CML specificity comparable to 11J.-derived CTLs . CML reactions were also performed in all
combinations using 5 x 10' CTLs pertube ; while the percent cytotoxicity was less than that
shown for 25 x 10° CTLs per tube, the specificity ofcytotoxicity and blocking was identical.
The percent cytotoxicity mediated on all four targets (H, J, K, and U), by each of the five
blocker populations in the absence ofany CTLs ranged from -2 .3 to 3.9, and did not differ
significantly from 0 . Control values for each target : H : SR, 213 ± 28 ; max., 2,083 ± 48 ; J :
SR, 143 ± 39 ; max., 1,411 ± 6 ; andU : SR, 244 ± 40; max., 1,989 ± 68 .
structures differently . In either case the CTL antigen receptor demonstrates
different recognitive specificitythan the antigen-binding site ofthe immunoglob-
ulin (27) .
Alternatively, the antigens recognized by CTLsmight not be controlledby the
SD loci, butinsteadby differentcloselylinked loci within theSD regions . Under
these conditions, the impressive correlation of SD antigen sharing with the
magnitude of the CML reaction would be attributed to linkage disequilibrium .
This would demonstrate a far greater recognitive dichotomy between immuno-
globulins directed at SD antigens and in vitro sensitized CTLs directed at still
some other target molecule .
Summary
The specificity of antigen recognitionby in vitro sensitized human cytotoxicT
lymphocytes (CTLs) has been studied using a sensitive cell-mediated lympho-
lysis (CML) assay . Frequently, high levels of cytotoxicity are observed on third-
party targets unrelatedto sensitizing or responding cells; however, no cytotoxic-ity differing significantly from zero has been observed on targets autologous to
the responding CTLs . This "cross-killing" of third-party target cells has been
observed when stimulating and third-party cells bear no cross-reacting serologi-
cally defined (SD) antigens, thought to be the target antigens recognized by
CTLs . CML-blocking studies, using unlabeled normal human lymphocytes to
inhibit s'Cr releasefrom radiolabeled target cells, have shown that cross-killing,
even in the absence of shared SD determinants, results from CTLs recognizing
antigens shared by the third-party targets and the initial stimulating popula-
tion . Furthermore, these antigenshave beenmapped to the major histocompati-
bility complex (MHC) . The ability of human CTLs to specifically recognize
MHC-controlled antigens not detected serologically suggests that SD antigens
may be recognized differently by alloantisera and CTLs, or thatMHC antigens
other than SD may be the targets of CTLs in CML .
We wish to thank Dr . Rudolf Wank for kindly performing all serological testing required for these
studies, Sheelah Anderson for the preparation of this manuscript, and Andrew Hong for drawing
all figures. Special thanks are given to Marc Jacobson and Genia Gordon for long hours ofdiligent
expert technical assistance .
Received for publication 24 April 1975 .




1 . Hayry, P ., andV . Defendi . 1970 . Mixed lymphocyte cultures produce effector cells : a
model in vitro for allograft rejection . Science (Wash . D . C .) . 168 :133 .
2 . Svedmyr,E . A . J ., andR. Hodes . 1970 . On the specificity of cell-mediated cytotoxicity
in vitro . Cell . Immunol . 1 :644 .
3 . Solliday, S., and F . H . Bach . 1970 . Cytotoxicity ; specificity after in vitro sensitiza-
tion . Science (Wash . D . C .) . 170:1406 .
4 . Lightbody, J . J ., D . Bernoco, V . C . Miggiano, and R. Ceppellini . 1971 . Cell mediated
lympholysis . G . Batteriol . Virol ., Immunol . Ann . Osp . Maria Vittoria Torino .
64:243.
5 . Wagner, H . 1971 . Cell-mediated immune response in vitro : independent differentia-
tion of thymocytes into cytotoxic lymphocytes . Eur . J . Immunol . 1 :498 .
6 . Hayry, P ., L . C . Andersson, S . Nordling, andM . Virolainen. 1972 . Allograft response
in vitro . Transplant . Rev . 12 :91 .
7 . Sondel, P . M ., L . Chess, R . P . MacDermott, and S . F . Schlossman . 1975 . Immuno-
logic functions of isolated human lymphocyte subpopulation . III . Specific allogeneic
lympholysis mediated by human T cells alone . J . Immunol . 114:982 .
8 . Trinchieri, G ., D . Bernoco, S . E . Curtoni, V . C . Miggiano, and R . Ceppellini . 1972 .
Cell mediated lympholysis in man : relevance of HL-A antigens and antibodies . In
Histocompatibility Testing 1972 . J . Dausset and J . Colombani, editors . Munksgaard,
Copenhagen, Denmark, 509 .
9 . Eijsvoogel, V . P ., M . J . G . J . du Bois, A. Meinesz, A . Bierhorst-Eijlander, W . P.
Zeylemaker, and P . Th . A . Schellekens . 1973 . The specificity and activation mecha-
nism of cell-mediated lympholysis (CML) in man . Transplant . Proc . 5:1675 .
10 . Bonnard, G . D ., M . Chappuis, A . Glauser, W . Mempel, P . Baumann, H . Grosse-
Wilde, and E . D . Albert . 1973 . SD vs . LD antigens as targets for lymphocyte-
mediated cytotoxicity : study of a family presenting a recombination event within the
MHR . Transplant . Proc . 5:1679 .
11 . Schendel, D . J ., B . J . Alter, and F . H . Bach. 1973 . Involvement ofLD and SD region1348 RECOGNITIVE SPECIFICITY OF HUMAN CYTOTOXIC T LYMPHOCYTES
differences in MLC and CML : a "three-cell" experiment. Transplant. Proc. 51651 .
12 . Grunnet, N., T. Kristensen, F. Jorgensen, and F . Kissmeyer-Nielsen. 1974. The
impact of SD determinants on in vitro induced lympholysis. Tissue Antigens . 4218.
13. Brondz, B. D ., I. K. Egorov, and G. I . Drizlikh . 1975. Private specificites ofH2-K and
H2-D loci as possible selective targets for effector lymphocytes in cell mediated
immunity. J. Exp . Med . 141 :11.
14. Mittal, K. K., and P. I. Terasaki. 1974. Serological cross-reactivity in the HL-A
system . Tissue Antigens . 4 :146 .
15. Ortiz de Landazuri, M., and R. B. Herberman. 1972. Specificity of cellular immune
reactivity to virus induced tumours. Nat. New Biol. 238:18.
16. Rosenberg, E. B., J. L . McCoy, S . S. Green, F. C . Donnelly, D. F. Siwarski, P. H.
Levine, and R. B . Herberman. 1974. Destruction of human lymphoid tissue-culture
cell lines by human peripheral lymphocytes in 5'Cr-release cellular cytotoxicity
assays. J. Natl. Cancer Inst. 52:345.
17. Bevan, M . J. 1975. Alloimmune cytotoxic T cells: evidence that they recognize
serologically defined antigens and bear clonally restricted receptors. J. Immunol.
114 :316.
18. Hartzman, R. J., M. Segall, M. L. Bach, and F. H. Bach. 1971. Histocompatibility
matching. VI. Miniaturization of the mixed leukocyte culture test. Transplantation
(Baltimore). 11:268.
19. Terasaki, P. I., and J. D. McClelland. 1964. Microdroplet assay of human serum
cytotoxins. Nature (Lond.). 204:998.
20. Mayr, W. R., D. Bernoco, M. De Marchi, and R. Ceppellini. 1973 . Genetic analysis
and biological properties of products of the third SD (AJ) locus of the HL-A region.
Transplant. Proc . 5 :1581 .
21. Canty, T. G., J. R. Wunderlich, and F. Fletcher. 1971. Qualitative and quantitative
studies of cytotoxic immune cells. J. Immunol. 106:200.
22. Hollander, N., and H. Ginsburg. 1972. Specific adherence of in vitro differentiated
lymphocytes to target cells. J. Exp . Med. 136:1344.
23. Bach, F. H ., M. Segall, K. S. Zier, P. M. Sondel, B. J. Alter, and M. L. Bach. 1973.
Cell mediated immunity: separation of cells involved in recognitive and destructive
phases. Science (Wash . D . C .). 180:403.
24. Bach, F. H., K. S. Zier, and P. M. Sondel. 1973. The nature of cells responding in
mixed leukocyte cultures and cell-mediated lympholysis. Transplant. Proc. 5:1717.
25. Willumsen, J., and I. Heron. 1974. Cell mediated lympholysis in man . A case of"non-
relevant" killing of third-party persons. Tissue Antigens. 4 :172.
26. Kristennsen, T., N. Grunnet, and F. Kissmeyer-Nielsen. 1974. CML in man, occur-
rence of unexpected HL-A "irrelevant" lympholysis. Tissue Antigens. 4:378.
27. Bach, F. H., M. L . Bach, P. M. Sondel, and G. Sundharadas. 1972. Genetic control of
mixed leukocyte culture reactivity. Transplant. Rev . 12 :30.